Insights into Company

Omaxe Limited

📍 Gurugram, Delhi, India Active NSE OMAXE CIN L74899HR1989PLC051918
Search companies

Key Metrics of Omaxe Limited

Revenue₹454 Cr▲ 16.4% YoYFY 2025-26
EBITDA−₹81.2 Cr▼ 45.9% YoY
Net profit−₹196 Cr▲ 9.9% YoY
Net worth₹461 Cr▼ 29.9% YoY

About Omaxe Limited

Company details

Registered office
Shop No-19-b, First Floor Omaxe Celebration Mall, Sohna Road, Gurugram, In-hr, 122001
Listed
NSE: OMAXE · ₹103.84

Company summary

Entity details

CINL74899HR1989PLC051918
LEI code3358007IGGTMNOLUEX72
State codeHR
PIN code122001
Current legal nameOMAXE LIMITED
Classification—
Listing statusListed (NSE: OMAXE)
Registration no.051918
Company age—
PAN—
CountryIndia
CityGurugram
StateDelhi
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code74899
Description of main activityOther business activities (consultancy, engineering, advertising, staffing)
Description of business activityOther business activities (consultancy, engineering, advertising, staffing)
SectorOther Industries · Discovered Companies
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 3 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 33 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 12 Oct 2026 CARE BB+ Stable outlook · Short term A4+ · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on record▼ 1 notchsince Jan 2019
Rating actions140 up · 1 down
Liquidity (CARE)Adequate

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
12 Oct 2026CAREReaffirmed BB+A4+Stable₹80.8 Cr View
13 Oct 2025CAREReaffirmed BB+A4+Stable₹111 Cr View
24 Sep 2024CAREDowngraded BB+—Stable₹282 Cr View
27 Aug 2024CAREOther ———— View
08 Aug 2024CARERevised BBB-—Negative₹282 Cr View
05 Jul 2024CAREReaffirmed BBB-A3Stable₹282 Cr View
21 Aug 2023CAREReaffirmed BBB-—Stable₹290 Cr View
12 Aug 2022CARERevised (from BB) BBB-A3Stable₹947 Cr View
22 Jun 2022CAREOther ———— View
07 Jan 2022CAREReaffirmed BBA4Stable₹598 Cr View
18 Nov 2021CARERevised (from D) BBA4Stable₹21.0 Cr View
05 Mar 2021CARERevised D—Stable₹1,292 Cr View
03 Apr 2020CARERevised (from BBB) BB+—Stable₹1,315 Cr View
07 Jan 2019CARERevised BBB-—Negative₹1,500 Cr View

Credit strengths (CARE, Oct 2026)

+ Experienced promoters with long track record in real estate sector

The group benefits from the strong industry experience of its promoters, led by Mr. Rohtas Goel and Mr. Mohit Goel, who have been associated with the real estate sector for over three decades. The promoter group held approximately 74.14% stake in Omaxe Limited as on March 31, 2026. Over the years, the group has established a sizeable presence across residential, township and commercial real estate segments and has executed over 145 million square feet of development projects, providing substanti

+ Healthy sales and collection momentum

The group continues to report healthy operating performance, supported by sustained demand across its residential and commercial portfolio. As on June 30, 2026, the group had sold ~280 lakh square feet area, representing a healthy booking ratio of ~80% of the launched inventory. The strong sales performance is reflected in cumulative booking value of ₹14,115 crore. Against this, the group has achieved collections of ₹9,248 crore, translating into realization of nearly 65% of booked sales value.

+ Advanced Stage of Execution of Ongoing Portfolios

The group's project portfolio is at a relatively advanced stage of execution, providing strong visibility on timely completion and revenue recognition. As on June 30, 2026, of the total project cost of ₹11,316 crore, ₹6,384 crore (56%) had already been incurred. Further, seven projects are at an advanced stage with over 70% cost already incurred, while most of the remaining projects have crossed the midway execution stage. Execution risk is further moderated by the group's large township and plo

+ Assumptions/Covenants: Not applicable

Environment, social, and governance (ESG) risks: Not applicable Applicable criteria Consolidation Definition of Default Liquidity Analysis of Non-financial sector entities Rating Outlook and Rating Watch Financial Ratios – Non financial Sector

+ Consolidated

Brief Financials (₹ crore) March 31, 2025 (A) March 31, 2026 (A) Q1FY27 (UA) Total operating income 1560.99 1253.40 406.17 PBILDT* -341.38 -85.51 7.32 Profit after tax (PAT) -685.40 -696.80 1.30 Overall gearing (x) -2.04 -1.42 NA Interest coverage (x) -0.74 -0.10 0.27 A: Audited; UA: Unaudited; NA: Not Available; Note: These are latest available financial results.

+ Total operating income 1560.99 1253.40 406.17

PBILDT* -341.38 -85.51 7.32 Profit after tax (PAT) -685.40 -696.80 1.30 Overall gearing (x) -2.04 -1.42 NA Interest coverage (x) -0.74 -0.10 0.27 A: Audited; UA: Unaudited; NA: Not Available; Note: These are latest available financial results. *PBILDT: Profit before interest, lease rentals, depreciation, and tax Status of non-cooperation with previous CRA: Not applicable

Credit challenges

− Adverse orders against the company

Recent SEBI order on Minimum Public Shareholding (MPS) compliance: SEBI vide order dated September 24, 2026, held Omaxe Limited and certain promoter-linked entities liable for routing ₹46.50 crore through group entities/ group individuals to acquire Omaxe shares in the 2013 offer-for-sale (OFS), resulting in misrepresentation of compliance with MPS norms. SEBI has restrained the company from accessing the securities market for three months and Rohtas Goel, Sunil Goel, Jai Bhagwan Goel, Dream Hom

− High dependence on customer advances for projects funding

The group continues to rely substantially on customer advances to fund project construction and development activities.Of the total estimated project cost of ~₹11,316 crore, nearly 84% is proposedto be funded through customer collections. 2 CARE Ratings Ltd. Press Release Consequently, the group's cash flow profile remains highly dependent on sustained sales momentum and timely realisation of receivables. Any slowdown in bookings, weakening customer demand, or delays in collections could increas

− High cost of borrowing and continued losses at Group level

The group's project debt carries a relatively high cost of borrowing, averaging ~13% per annum, which places pressure on project-level profitability and cash flow generation. OL has posted net losses in previous five fiscals. The group recognises revenue upon transfer of possessions. The revenue recognition in previous fiscals has been lower compared to the cost incurred in respective years. Currently, the group has been recognising revenue of projects that were launched prior to pandemic and ow

− Inherent cyclical nature of real estate industry

The group is exposed to cyclicality associated with the real estate sector, which has direct linkage with the general macroeconomic scenario, interest rates and level of disposable income available with individuals. In case of real estate companies, profitability highly depends on property markets. A high-interest rate scenario could discourage consumers from borrowing to finance real estate purchases and might depress the real estate market. OL group’s portfolio is across tier-I and tier-II cit

− Key strengths

Experienced promoters with long track record in real estate sector The group benefits from the strong industry experience of its promoters, led by Mr. Rohtas Goel and Mr. Mohit Goel, who have been associated with the real estate sector for over three decades. The promoter group held approximately 74.14% stake in Omaxe Limited as on March 31, 2026. Over the years, the group has established a sizeable presence across residential, township

− Healthy sales and collection momentum

The group continues to report healthy operating performance, supported by sustained demand across its residential and commercial portfolio. As on June 30, 2026, the group had sold ~280 lakh square feet area, representing a healthy booking ratio of ~80% of the launched inventory. The strong sales performance is reflected in cumulative booking value of ₹14,115 crore. Against this, the group has achieved collections of ₹9,248 crore, translating into realization of nearly 65% of booked sales value.

Could lead to an upgrade

• Significant increase in the size of project portfolio with maintenance of committed receivable coverage ratio over 80% while maintaining unsold inventory levels below 18 months, on a sustained basis. • Favourable outcome of different adverse orders, with out any material impact on the company’s reputation,

Could lead to a downgrade

• Deterioration in the committed receivable coverage ratio below 50%, on a sustained basis. • Significant decline in collections and resultant increase in funding from debt to total project cost over 40%. • Crystallisation of major tax liabilities or penalties, or any reputational event resulting in deterioration in the group’s financial risk profile and

Agency-reported financials (CARE, 12 Oct 2026)

MetricMarch 31, 2025March 31, 2026Q1FY27
Total operating income₹1,561 Cr₹1,253 Cr₹406 Cr
PBILDT*₹-,341.38 Cr₹-85.51 Cr₹7.32 Cr
Profit after tax (PAT)₹-,685.40 Cr₹-,696.80 Cr₹1.30 Cr
Overall gearing (x)-2.04×-1.42×—
Interest coverage (x)-0.74×-0.10×0.27×
Revenue growth (YoY)—−19.7%—
PAT margin−43.9%−55.6%0.3%

Borrowings & rated debt

Rated borrowing limits (latest)₹80.8 Cr
Peak rated limits₹1,500 CrJan 2019 · CARE
Limits raised0 times0 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term Short-term bankWorking capital & bank lines—₹28.6 Cr— BB+ (Stable)OtherCARE
facilitiesOther—₹52.3 Cr— A4+ReaffirmedCARE

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
Bank Guarantee₹35.6 CrCARE BB+; Stable
BG/LC₹28.6 CrCARE BB+; Stable / CARE A4+
Cash Credit—Withdrawn
Fixed Deposit—Withdrawn
Non Convertible Debentures—Withdrawn
Term Loan—Withdrawn
Term Loan₹16.6 CrCARE BB+; Stable

Lenders

Fund-based - LTTerm LoanPiramal Finance Ltd.
Non-fund-based - LTBank GuaranteeIndian Bank
Non-fund-based - LTBank GuaranteePunjab National Bank
Non-fund-based - LT/ STBG/LCState Bank of India

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequateAgency: Adequate
DirectionNegativeAgency outlook: Stable
CARE rating · Oct 2026BB+3 notches below indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultLast default 05 Mar 2021, cured 18 Nov 2021 (1802 days; investment grade needs 365)
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)48%
Information on file89% · missing: Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 48% (At risk of downgrade) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹80.81 Cr
Not yet allocated—
Extra debt within 2.5× EBITDA—
Interest coverage0.27×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 48% chance the next rating action is stable or better
  • Current rating BB+ (below investment grade)
  • Interest coverage 0.27×

What happened, step by step

Refinanced bank debt with new funding from Swamih Investment Fund
  1. Aug 2023 — ₹192 cr raised from Swamih Investment Fund
  2. Aug 2023 — Full repayment of debt

“Further, the group has also raised debt of Rs.192 cr during Q4FY23 from Swamih Investment Fund for the residential project in New Chandigarh “The Resort” out of which Rs.30 crores has already been disbursed as on June 30, 2023.”

Refinanced bank debt with new funding
  1. Aug 2023 — ₹542 cr raised
  2. Aug 2023 — Full repayment of debt

“High debt repayment in FY24 and H1FY25 offset by adequate liquidity buffer and committed receivable During FY23, Omaxe has repaid Rs. 500 Crores to lenders as principal payment and has raised debt of Rs.542 crores and has an outstanding debt of Rs.1333.16 crores as on March 31, 2023 as compared to debt of Rs.1357.16 cr...”

Refinanced bank debt with NCDs / bonds
  1. Aug 2023 — ₹440 cr raised through NCDs / bonds
  2. Aug 2023 — Full repayment of debt

“Of the debt being raised major one is the NCD of Rs.440cr due for repayment in Jul’25 along with the redemption premium at IRR of 18%.”

Refinanced bank debt with NCDs / bonds from Varde Partners
  1. Aug 2022 — ₹340 cr raised through NCDs / bonds from Varde Partners
  2. Aug 2023 — Full repayment of debt

“However, in Q1FY23 the debt level has increased due to issuance of NCDs of Rs. 440 crore (out of which Rs.340cr is raised till Jun 30, 2022) taken from Varde Partners.”

Capex funded with bank debt
  1. Oct 2025 — Term debt tied up
  2. Oct 2026 — Project / plant of ₹11,316 cr

“High dependence on customer advances for projects funding The group continues to rely substantially on customer advances to fund project construction and development activities.Of the total estimated project cost of ~₹11,316 crore, nearly 84% is proposedto be funded through customer collections. 2 CARE Ratings Ltd.”

Rated limits by facility

Timeline

12 Oct 2026 CARE reaffirmed: BB+ (Stable)Rated limits ₹80.81 cr CARE rationale
12 Oct 2026 Capex / project: ₹11,316 cr
From the report

High dependence on customer advances for projects funding The group continues to rely substantially on customer advances to fund project construction and development activities.Of the total estimated project cost of ~₹11,316 crore, nearly 84% is proposedto be funded through customer collections. 2 CARE Ratings Ltd.

CARE rationale
12 Oct 2026 Cash & liquid funds ₹587.4 cr
From the report

Press Release Liquidity: Adequate The group's liquidity profile remains adequate, supported by free cash and liquid investments of ₹587.40 crore and ₹585 crore as on March 31, 2026, and June 30, 2026, respectively.

CARE rationale
13 Oct 2025 CARE reaffirmed: BB+ (Stable)Rated limits ₹110.98 cr CARE rationale
13 Oct 2025 New borrowing arranged (term loans)
From the report

CARE Ratings Limited (CareEdge Ratings)has withdrawn the rating assigned tothe proposed bank facilities of OL with immediate effect, as the company has not availed this facility and requested for withdrawal.

CARE rationale
13 Oct 2025 Capex / project: ₹4,913 cr
From the report

Against these receivables, the company has balance project cost of ~₹4913 crore and outstanding debt of ₹560 crore.

CARE rationale
13 Oct 2025 ₹450 cr raised through NCDs / bonds from Oaktree Capital
From the report

As on August 31, 2025, the company’s total outstanding debt has risen to ₹1,128.57 crore, primarily due to the infusion of ₹450 crore through non-convertible debentures (NCDs) raised from funds managed by Oaktree Capital Management.

CARE rationale
13 Oct 2025 Cash & liquid funds ₹443.72 cr
From the report

Liquidity: Adequate As on March 31, 2025, the group maintained free liquid investments of close to ₹443.72 crore against scheduled debt commitments (including interest) of close to ₹320 crore in next four quarters.

CARE rationale
24 Sep 2024 CARE downgraded: BB+ (Stable)Rated limits ₹281.52 cr CARE rationale
24 Sep 2024 Capex / project: ₹8,000 cr
From the report

Sizeable future expansion plans to elevate execution risk Over next two years, the group has plans to launch new projects with overall project cost of ₹8,000 crore.

CARE rationale
24 Sep 2024 Cash & liquid funds ₹550 cr
From the report

Liquidity: Adequate As on June 30, 2024, OL had maintained free liquid investments of close to ₹550 crore against scheduled debt commitments (including interest) of close to ₹337 crore in next four quarters.

CARE rationale
24 Sep 2024 Cash & liquid funds ₹100 cr
From the report

The compensation awarded in favour of PDA is likely to result in cash outflow of over ₹100 crore.Additionally, cash outflow of another ₹100 crore is likely, when the company appeals against the land seizure by the Noida Authority.

CARE rationale
27 Aug 2024 CARE other: — CARE rationale
08 Aug 2024 CARE revised: BBB- (Negative)Rated limits ₹281.52 cr CARE rationale
08 Aug 2024 Capex / project: ₹8,000 cr
From the report

Key weaknesses Sizeable future expansion plans to elevate the execution risk Over the next two years, the group has plans to launch new projects with overall project cost of ₹8000 crore.

CARE rationale
08 Aug 2024 Cash & liquid funds ₹540 cr
From the report

As on March 31, 2024, OL ha d maintained free liquid investments of close to ₹540 crore against scheduled debt commitments (including interest) of close to ₹337 crore in next four quarters .

CARE rationale
08 Aug 2024 Cash & liquid funds ₹100 cr
From the report

Although, the compensation awarded in favour of PDA i s likely to result in cash outflow of over ₹100 crore, which will deteriorate the liquidity position of the company Assumptions/Covenants: Not applicable Environment, social, and governance (ESG) risks CARE Ratings believes that OL’s ESG profile supports its credit risk profile.

CARE rationale
05 Jul 2024 CARE reaffirmed: BBB- (Stable)Rated limits ₹281.52 cr CARE rationale
05 Jul 2024 Capex / project: ₹8,000 cr
From the report

Key weaknesses Sizeable future expansion plans to elevate the execution risk Over the next two years, the group has plans to launch new projects with overall project cost of ₹8000 crore.

CARE rationale
05 Jul 2024 Cash & liquid funds ₹540 cr
From the report

Although there is stable demand currently, adverse impact in these micro -markets will remain monitorable Liquidity: Adequate As on March 31, 2024, OL has maintained free liquid investments of close to ₹540 crore against scheduled debt commitments of close to ₹337 crore in next four quarters, which provides adequate liquidity cushion.

CARE rationale
21 Aug 2023 CARE reaffirmed: BBB- (Stable)Rated limits ₹290.06 cr CARE rationale
21 Aug 2023 Full repayment of debt (₹500 cr)
From the report

Also during FY23, Omaxe has repaid debt of Rs. 500 Crores to lenders as principal payment.

CARE rationale
21 Aug 2023 Partial repayment of NCD (₹440 cr)
From the report

The major portion of the cash flow is due on offer of possession and with the completion of the project and major portion of inventory being sold, the group is expecting large collection during the period of Nov 23 to Jun 24, of which partially it will be used for repayment of NCD of Rs.440cr and remaining will support the liquidity in the company..

CARE rationale
21 Aug 2023 ₹192 cr raised from Swamih Investment Fund
From the report

Further, the group has also raised debt of Rs.192 cr during Q4FY23 from Swamih Investment Fund for the residential project in New Chandigarh “The Resort” out of which Rs.30 crores has already been disbursed as on June 30, 2023.

CARE rationale
21 Aug 2023 ₹542 cr raised
From the report

High debt repayment in FY24 and H1FY25 offset by adequate liquidity buffer and committed receivable During FY23, Omaxe has repaid Rs. 500 Crores to lenders as principal payment and has raised debt of Rs.542 crores and has an outstanding debt of Rs.1333.16 crores as on March 31, 2023 as compared to debt of Rs.1357.16 crores as on March 31, 2022.

CARE rationale
21 Aug 2023 ₹440 cr raised through NCDs / bonds
From the report

Of the debt being raised major one is the NCD of Rs.440cr due for repayment in Jul’25 along with the redemption premium at IRR of 18%.

CARE rationale
21 Aug 2023 Full repayment of debt (₹63 cr)
From the report

The group has already repaid debt of Rs.63 crores during Q1FY24 funded through the customer collections.

CARE rationale
21 Aug 2023 Cash & liquid funds ₹191.74 cr
From the report

Also, the group has unencumbered cash and bank balance of Rs.191.74 crores as on March 31, 2023 High cost of borrowing The debt taken by the group to fund the ongoing projects constitutes high cost of borrowing ranging ~14%-18%.

CARE rationale
12 Aug 2022 CARE revised: BBB- (Stable)Rated limits ₹947.18 cr CARE rationale
12 Aug 2022 ₹340 cr raised through NCDs / bonds from Varde Partners
From the report

However, in Q1FY23 the debt level has increased due to issuance of NCDs of Rs. 440 crore (out of which Rs.340cr is raised till Jun 30, 2022) taken from Varde Partners.

CARE rationale
12 Aug 2022 Full repayment of term loans (₹1,912 cr)
From the report

Healthy collections leading to prepayment of term loans The company had collections of Rs.1912 crores in FY22 as against Rs.1295 crores in FY21.

CARE rationale
12 Aug 2022 ₹340 cr raised
From the report

Apart from this the company has raised debt of Rs.340cr during Q1FY23 (out of sanctioned debt of Rs.440cr) against its Chandni Chowk project specifically.

CARE rationale
12 Aug 2022 Partial repayment of debt (₹440 cr)
From the report

Also, the funding from Varde partners i.e NCDs of Rs.440 crores constitutes IRR of ~18% which was partially used in the prepayment of debt and partially for the completion of its Chandni Chowk project in Delhi, scheduled for delivery in FY23.

CARE rationale
12 Aug 2022 Partial repayment of debt (₹220 cr)
From the report

The group has already repaid debt of Rs.220 crores during Q1FY23 partially funded through the customer collection and partially through refinancing.

CARE rationale
12 Aug 2022 Cash & liquid funds ₹126.55 cr
From the report

Also, the group has unencumbered cash and bank balance of Rs.126.55 crores as on March 31, 2022 and ~Rs.150 crores as on June 30, 2022 along with the undisbursed amount of ~Rs.100 crores as on June 30, 2022.

CARE rationale
12 Aug 2022 Cash & liquid funds ₹4,106 cr
From the report

Further the future cash flow are supported by the receivable of Rs.4106 crores as on April 30, 2022 from confirmed sales along with the unsold inventory of Rs.6549 crores.

CARE rationale
22 Jun 2022 CARE other: — CARE rationale
07 Jan 2022 CARE reaffirmed: BB (Stable)Rated limits ₹598.49 cr CARE rationale
18 Nov 2021 CARE revised: BB (Stable)Rated limits ₹21 cr CARE rationale
18 Nov 2021 Full repayment of debt
From the report

Since then there has no delay or default in the repayment of debt and also there is no auditor comment on delay and default in the annual report for FY21 and the same is confirmed by the bankers.

CARE rationale
05 Mar 2021 CARE revised: D (Stable)Rated limits ₹1,292 cr CARE rationale
05 Mar 2021 Full repayment of debt
From the report

Thirty -Six Crore and Forty-Seven Lakhs Only) Details of instruments/facilities in Annexure-1 Detailed Rationale & Key Rating Drivers The rating has been revised on account of delays in servicing of its debt obligations due to stressed liquidity position resulting from the slowdown in real estate market due to covid-19 Key Rating Sensitivity Positive Factors  Timely repayment of its debt on timely basis.  Timely completion of the project within the estimated timelines Detailed description of the key rating drivers Key Rating Weaknesses Delays in servicing of debt obligations There have been

CARE rationale
03 Apr 2020 CARE revised: BB+ (Stable)Rated limits ₹1,315 cr CARE rationale
03 Apr 2020 Cash & liquid funds ₹91 cr
From the report

Free cash balance was Rs. 91 cr as on December 31, 2019.

CARE rationale
03 Apr 2020 Capex / project: ₹1,296 cr
From the report

Large land bank, majority of which is paid for As on Dec 31, 2019, Omaxe had approximately 901 acres of land (excluding land on which ongoing projects are being executed) acquired at total cost of Rs. 1,296 crore.

CARE rationale
03 Apr 2020 ₹110 cr of limits rated but not yet allocated to a lender CARE rationale
07 Jan 2019 CARE revised: BBB- (Negative)Rated limits ₹1,500 cr CARE rationale
07 Jan 2019 Cash & liquid funds ₹90.54 cr
From the report

Liquidity The liquidity of the company was moderate with unencumbered cash and cash equivalents stood at Rs.90.54 crore as on March 31, 2018 and Rs.79 crore as on September 30, 2018.

CARE rationale
07 Jan 2019 Cash & liquid funds ₹745 cr
From the report

The company has significant repayment obligations in the medium term, however stable cash collections of around Rs.745 cr in H1 FY19 have supported the operations.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeSHOP NO-19-B, FIRST FLOOR OMAXE CELEBRATION MALL, SOHNA ROAD, GURUGRAM, IN-HR, 122001
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.